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Abstract
Background: This study aimed to elucidate the phenotypic, immunologic, and clinical characteristics of Korean
patients with nontuberculous mycobacterial (NTM) lung disease and compare them with non-NTM bronchiectasis
(BE) patients.
Methods: We prospectively recruited patients between 20 and 80 years of age who had nodular BE type NTM lung
disease. Phenotypic, immunologic, and clinical characteristics were evaluated through physical examination,
laboratory tests, pulmonary function tests, and radiographic examinations. Questionnaires were also answered. The
results of the evaluations were compared with the results of non-NTM BE patients.
Results: A total of 84 patients with NTM lung disease and 47 non-NTM BE patients participated in the study.
Mycobacterium avium complex lung disease and M. abscessus lung disease were most common. Patients with NTM
lung disease had lower body mass index than non-NTM BE patients. Scoliosis was observed more frequently in
patients with NTM lung disease than in non-NTM BE patients.
Conclusions: Significant similarities were seen between Korean patients with NTM lung disease and patients from
other countries. Differences in phenotypic and clinical characteristics between NTM lung disease and non-NTM BE
patients suggest differences in the immunopathogenesis of NTM lung disease and non-NTM BE.
Trial registration information: ClinicalTrials.gov Registration number; NCT01616745
Keywords: Bronchiectasis, Clinical characteristics, Immunopathogenesis, Nontuberculous mycobacterial lung
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Background
Nontuberculous mycobacteria (NTM) are environmen-
tally ubiquitous organisms, and rarely cause disease in
healthy individuals. Rates of NTM isolation, as well as
the number of patients with NTM lung disease, have
been increasing worldwide [1]; however, the fact that
only a small number of people contract NTM despite
ubiquitous exposure suggests the presence of identifiable
risk factors associated with NTM infection.
While the immunopathogenesis of NTM lung disease
remains largely unknown, certain phenotypic and immuno-
logic characteristics of patients with NTM lung disease
have been observed. A single nucleotide polymorphism in
TLR2 has been linked to NTM lung diseases [2], and IFN-γ
and IL-10 secretions have been reported to be suppressed
among patients with NTM lung disease [3]. Furthermore,
patients with NTM lung disease tend to be taller and leaner
on average, with relatively high frequencies of scoliosis, pec-
tus excavatum, and mitral valve prolapse [4].
While the incidence of tuberculosis has been in steady
decline across South Korea, the rate of NTM isolation
has increased rapidly [5]. The aim of this study was to
elucidate the phenotypic, immunologic, and clinical
characteristics of Korean patients with NTM lung
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Beginning July 1, 2011 we prospectively recruited pa-
tients between 20 and 80 years of age at Seoul National
University Hospital, Seoul, South Korea, who met the
diagnostic criteria for NTM lung disease set forth by the
American Thoracic Society [6]. Patients previously
treated for NTM lung disease were excluded from this
study. NTM patients with nodular BE types were in-
cluded but those with upper lobe cavitary types were ex-
cluded. All patients provided written informed consent
before enrollment. The study protocol was approved by
the Institutional Review Board of Seoul National University
Hospital. The clinical trial registration number is NCT
01616745 (www.ClinicalTrials.gov).
Control group
Beginning January 1, 2012 we began recruiting patients ≥
20 years old diagnosed with BE in the absence of NTM
infection (non-NTM) to serve as a control group. BE
was diagnosed based on low dose computed tomography
(CT) findings that included dilatation of an airway
lumen, rendering it more than 1.5 times the width of
a nearby vessel, lack of tapering of an airway toward the
periphery, varicose constrictions along airways, and bal-
looned cysts at the end of a bronchus [7]. Two separate
sputum mycobacterial cultures were performed to exclude
patients with active NTM infections. The median interval
between the two cultures was 24 months (interquartile
range: 9–55 months).
Physical examinations
Physical examinations were performed by board-certified
physicians. Height and weight were measured by a team
of two nurses.
Microbiological tests
Sputum was collected for bacterial and mycobacterial
cultures. Samples of sputum were homogenized by
incubation at 37°C for 15 min with an equal volume
of 0.1% dithiothreitol (Sputolysin; Calbiochem Corp.,
San Diego, CA, USA). Homogenized sputum was se-
quentially diluted and placed in phosphate-buffered
saline and plated on blood, chocolate, and MacConkey
agar plates. Sputum isolates were classified as poten-
tial pathogens or as normal flora. Potential pathogens
were Haemophilus influenzae, Moraxella catarrhalis,
Streptococcus pneumoniae, Pseudomonas aeruginosa,
Staphylococcus aureus, and other gram-negative rods;
other bacterial species were classified as normal
flora [8].
Sputum and bronchial washing fluid were decontami-
nated with 4% sodium hydroxide, homogenized, and
concentrated by centrifugation at 3000 × g for 20 min.
The specimens were stained using the Ziehl–Nielsen
method [6]. Concentrated specimens were cultured in
3% Ogawa medium and observed weekly for 9 weeks
after inoculation. Following isolation of a suspected
mycobacterial species, confirmation of NTM was per-
formed by analyzing the sequences of three genes; 16S
rRNA, rpoB and tuf. Polymerase chain reaction and sub-
sequent sequencing were performed, and the resulting
sequences were compared with the reference database
using basic local alignment search tools. Mycobacterial
species were identified using 16S rRNA sequences, using
the algorithm described in Clinical and Laboratory
Standards Institute guideline MM18-A [9].
Laboratory tests
Laboratory tests consisted of the following: leukocyte count
including differential counts, hematocrit, hemoglobin,
platelet count, total cholesterol, total protein, albumin, total
and direct bilirubin, alkaline phosphatase, aspartate
aminotransferase, alanine aminotransferase, blood urea
nitrogen, creatinine, electrolytes, erythrocyte sedimen-
tation rate, C-reactive protein, fluorescent antinuclear
antibody test (FANA), rheumatoid factor, serum im-
munoglobulins (IgG, IgA, IgM), and IFN-γ release
assay (IGRA).
Pulmonary function tests and radiographic examination
Pulmonary function tests, including forced expiratory
volume at 1 second (FEV1), forced vital capacity (FVC),
FEV1/FVC ratio, and diffusing capacity (DLCO) were
performed. Simple posterior–anterior chest radiography,
paranasal sinus radiography, and CT of the chest were
carried out. Radiographic findings on CT scans were
evaluated with regard to the presence of cavitations,
nodule, and bronchiectasis. The anatomical distributions
were also analyzed. Lesions were classified as showing
either upper lobe cavitary disease or nodular bronchiec-
tatic disease by radiographic type. When the disease did
not belong to either the upper lobe cavitary form or the
nodular bronchiectatic form, it was categorized as un-
classifiable. The extent of bronchiectasis was scored in
each of the six lobes (right upper lobe, right middle lobe,
right lower lobe, upper division of the left upper lobe,
lingular division of the left upper lobe, left lower lobe)
according to the proportion of lung involvement. Extent
scores ranged from 0 to 18; 0 if < 25%, 1 if 25–49%, 2 if
50–74%, 3 if ≥ 75% [10]. Scoliosis was determined from
the posterior–anterior chest radiograph. Pectus excava-
tum was determined from CT scans of the chest using
the Haller index and defined as a Haller index greater
than 3.5 [11].
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Questionnaires
All participants were asked to complete the St. George’s
respiratory questionnaire and Hospital Anxiety and
Depression Scale (HADS) questionnaire. The HADS is a 14
item questionnaire measuring levels of anxiety (HADS-A,
seven items) and depression (HADS-D, seven items). Each
item is scored from 0–3; a cut-off point of 8 out of 21 is
suggested for both the anxiety and depression sections [12].
Analysis
Baseline characteristics were summarized using descrip-
tive statistics such as proportion, median, and interquartile
range. Student’s t-tests and Mann–Whitney U-tests were
used for comparison of continuous variables. Categorical
variables were compared using chi-square or Fisher’s exact
tests, as appropriate. A P-value of ≤ 0.05 was considered to
indicate statistical significance. All statistical analyses were
performed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA).
Results
Patient characteristics
A total of 127 patients with NTM lung disease were
enrolled in the study, with eight patients withdrawing
consent prior to study completion. Among them, 84
patients with nodular BE type NTM lung disease were
included in the study. In addition, 50 patients with
non-NTM BE were initially enrolled in the study; three
patients withdrew consent. The median ages were 67
and 64 years for NTM lung disease and non-NTM BE
groups, respectively (P = 0.16). Of the patients with NTM
lung disease, 54 (64.3%) were female, compared with 29
(61.7%) in the non-NTM BE group. Among comorbidities,
cancer was more common among the NTM lung disease
group (21.4% vs. 6.4%, P = 0.03) (Table 1). Weight loss was
more common among the NTM lung disease group al-
though it failed to reach the conventional P-value of 0.05.
(15.5% vs. 4.3%, P = 0.08) (Table 1).
Microbiology analysis of patient sputum
Of the 84 patients with NTM lung disease, 47 (60.0%) were
infected with species belonging to the Mycobacterium
avium complex; 11 (13.1%) were infected with M. absces-
sus complex species. Multiple NTM species were isolated
in 20 (23.8%) patients (Table 2). Bacterial colonization by
non-mycobacterial species was observed in 17 (20.2%) and
12 (25.5%) of NTM lung disease and non-NTM BE pa-
tients, respectively (P = 1.00). The trend that P. aeruginosa
was more commonly isolated from non-NTM BE patients
(5 patients, 10.6%) than NTM patients (2 patients, 2.4%)
was observed (P = 0.10) (Table 3).
Phenotypic characteristics of the participants
No difference in height was observed between NTM lung
disease and non-NTM BE patients (160.0 vs. 159.0 cm, P =
0.23). However, patients with NTM lung disease were of
lower body weight than those with non-NTM BE (54.0 vs.
55.5 kg, P = 0.04); consequently, the body mass index (BMI)
of NTM lung disease patients was also lower than that of
non-NTM BE patients (BMI = 20.8 vs. 22.2 kg/m2, P <
0.001). Scoliosis was more common among patients with
NTM lung disease than those with non-NTM BE (23.8%
vs. 8.5%, P = 0.04) (Table 4).
Immunologic parameters of participants
Positive rheumatoid factor was detected more frequently
in patients with non-NTM BE than with NTM lung dis-
ease (23.4% vs. 6.0%, P = 0.01); however, differences in
mean rheumatoid factor levels were not statistically sig-
nificant. No differences were seen regarding the presence
Table 1 Baseline characteristics of 84 patients with NTM







(N = 84) (N = 47)
Age (year), median (IQR) 67 (57,75) 64 (58,70) 0.16
Female 54 (64.3%) 29 (61.7%) 0.85
Never smoker 57 (67.9%) 35 (74.5%) 0.55
BCG scar 170 (83.3%) 40 (85.1%) 1.00
Past medical history
TB 23 (27.4%) 20 (42.6%) 0.08
Measles 15 (17.9%) 15 (31.9%) 0.08
Pertussis 4 (4.8%) 4 (8.5%) 0.46
Comorbidities
aSinusitis 26 (31.0%) 15 (31.9%) 1.00
COPD 17 (20.2%) 17 (37.0%) 0.06
Asthma 3 (3.6%) 1 (2.2%) 1.00
Gastroesophageal
reflux disease
15 (17.9%) 11 (23.4%) 0.50
Diabetes mellitus 8 (9.5%) 1 (2.1%) 0.16
Rheumatoid arthritis 9 (10.7%) 2 (4.3%) 0.33
Cancer 18 (21.4%) 3 (6.4%) 0.03
Symptoms
Cough 25 (29.8%) 16 (34.0%) 0.70
bDyspnea 6 (7.1%) 6 (12.8%) 0.40
Sputum 39 (46.4%) 29 (61.7%) 0.10
Fever 16 (19.0%) 12 (25.5%) 0.38
Hemoptysis 19 (22.9%) 17 (36.2%) 0.15
Post nasal drip 25 (29.8%) 20 (42.6%) 0.18
Weight loss 13 (15.5%) 2 (4.3%) 0.08
Abbreviations: NTM nontuberculous mycobacteria, BE bronchiectasis,
TB tuberculosis, IQR interquartile range, COPD chronic obstructive
pulmonary disease.
aDiagnosis of sinusitis was based on self-reporting.
bDyspnea was defined as modified Medical Research Council score ≥ 2.
Lee et al. BMC Infectious Diseases 2013, 13:558 Page 3 of 7
http://www.biomedcentral.com/1471-2334/13/558
of FANA, nor in FANA titers. Serum immunoglobulin
levels were also similar between the two groups. Likewise,
the proportion of IGRA-positive patients were similar in
NTM lung disease patients and non-NTM BE patients
(45.2 vs. 55.3%, P = 0.28) (Table 5).
Radiological characteristics
The extent of BE was greater in the non-NTM BE group
than in nodular bronchiectatic NTM lung disease patients
(4 vs. 3 points, P = 0.001). Tubular BE was most common
in both groups (Table 6).
Pulmonary function
No differences in FVC were observed between NTM
lung disease patients and non-NTM BE patients in
terms of either absolute volume (2.8 vs. 2.7 L, P = 0.13)
although percentage of predicted volume were smaller
among non-NTM BE patients (94% vs. 87%, P = 0.02).
Table 2 Mycobacterial species isolated from 84 patients with NTM lung disease
The number of patients with isolation of single species 64/84 (76.2%)
Mycobacterium avium complex 47 (60.0%)
M. avium 27 (32.1%)
M. intracellulare 18 (21.4%)
Mixed 2 ( 2.4%)
M. abscessus complex 11 (13.1%)
M. abscessus 7 ( 8.3%)
M. massiliense 2 ( 2.4%)
Mixed 2 ( 2.4%)
M. chimaera 1 (1.2%)
M. kansasii 1 (1.2%)
M. fortuitum complex 1 (1.2%)
M. lentiflavum 1 (1.2%)
M. senegalense or conceptionense 1 (1.2%)
Unidentified 1 (1.2%)
The number of patients with isolation of multiple species 20/84 (23.8%)
M. avium complex and others 6 (7.1%)
M. avium and M. chelonae 1 (1.2%)
M. avium and M. chimaera 1 (1.2%)
M. avium and M. fortiutum 1 (1.2%)
M. avium and M. fortiutum and M. kansasii 1 (1.2%)
M. intracellulare and M. chitae 1 (1.2%)
M. intracellulare and M. fortuitum 1 (1.2%)
M. abscessus complex and others 5 (6.0%)
M. abscessus and M. chelonae 1 (1.2%)
M. abscessus and M. conceptionense 1 (1.2%)
M. abscessus and M. bolletii 2 (2.4%)
M. bolletii and M. lentiflavum 1 (1.2%)
M. avium complex and M. abscessus complex 7 (8.3%)
M. avium and M. absecessus 4 (4.8%)
M. avium and M. massilience 1 (1.2%)
M. avium and M. intracelullare and M. abscessus 1 (1.2%)
M. avium and M. absecessus and M. massiliense 1 (1.2%)
Others 2 (2.4%)
M. chimaera and M. peregrinum 1 (1.2%)
M. gordonae and M. kyorinense 1 (1.2%)
Abbreviations: NTM nontuberculous mycobacteria lung disease.
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Both absolute volume of FEV1 (2.1 vs. 1.8 L, P = 0.001)
and percentage of predicted volume (101% vs. 86%,
P = 0.001) were smaller among non-NTM BE patients.
However, the proportion of patients who met criteria for
chronic obstructive pulmonary disease was not different
between two groups (13.6% vs. 23.9%, P = 0.15) (Table 7).
Quality of life and emotional status
Median St. George’s respiratory questionnaire scores
were similar between the two groups (19.5 vs.18.1, P =
0.34). Twenty patients (23.8%) with NTM lung disease
and 10 patients (21.3%) with non-NTM BE reported
anxiety (P = 0.83). Twenty-three 23 patients (27.4%) with
NTM lung disease and 10 patients (21.3%) with non-
NTM BE reported symptoms of depression (P = 0.53).
Discussion
Through this prospective study, we collected phenotypic,
immunologic, and other clinical data from patients with
nodular BE type NTM lung disease and compared them
with those of BE patients. These data confirmed several
Table 3 Bacterial colonization of respiratory tract among 84 patients with NTM lung diseases and 47 non-NTM BE
patients
NTM lung diseases
patients (N = 84)
Non-NTM BE
patients (N = 47)
P value
Any isolates 17 (20.2%) 12 (25.5%) 1.00
Single isolate in one patient 15 (19.7%) 12 (26.7%) 0.38
Klebsiella pneumoniae 4 (4.8%) 5 (10.6%) 0.28
Streptococcus pneumoniae 1 (1.2%) 1 (2.1%) 1.00
Streptococcus species, viridans group 1 (1.2%) 0 1.00
Methicillin-sensitive Staphylococcus aureus 1 (1.2%) 0 1.00
Methicillin-resistant Staphylococcus aureus 2 (2.4%) 0 0.54
Pseudomonas fluorescens 1 (1.2%) 0 1.00
Pseudomonas putida 1 (1.2%) 0 1.00
Pseudomonas aeruginosa 2 (2.4%) 5 (10.6%) 0.10
Aeromonas hydrophila 1 (1.2%) 1 (2.1%) 1.00
Neisseria species 1 (1.2%) 0 1.00
Multiple microorganisms 2 (2.4%) 0 0.54
Methicillin-sensitive Staphylococcus aureus and Pseudomonas fluorescens 1 (1.2%) 0 1.00
Methicillin-resistant Staphylococcus aureus and Klebsiellapneumoniae 1 (1.2%) 0 1.00
Abbreviations: NTM nontuberculous mycobacteria, BE bronchiectasis.
Table 4 Phenotypic characteristics of 84 patients with
NTM lung disease and 47 non-NTM BE patients
NTM lung
disease







160.0 (156.0,168.0) 159.0 (153.0, 167.0) 0.23
Weight (kg),
median (IQR)
54.0 (48.3, 60.0) 55.5 (51.0, 63.0) 0.04
BMI (kg/m2),
median (IQR)
20.8 (19.3, 22.1) 22.2 (20.5, 24.2) <.001
Scoliosis, n (%) 20 (23.8%) 4 (8.5%) 0.04
Pectus
excavatum*, n (%)
6 (7.1%) 0 (0.0%) 0.09
Abbreviations: NTM nontuberculous mycobacteria, BE bronchiectasis,
IQR interquartile range. *Pectus excavatum was defined if the Haller
index was > 3.5.
Table 5 Immunological parameters of 84 patients with
NTM lung disease and 47 non-NTM BE patients
NTM lung
disease
patients N = 84
Non-NTM BE
patients N = 47
P value
Positive RF 5 (6.0%) 11 (23.4%) 0.01
RF level (0–9.9 IU/mL)*,
median (IQR)
16 (15,92) 18 (15,86) 0.88
Positive FANA 11 (13.1%) 2 (4.3%) 0.14
FANA titer, median (IQR) 40 (40,50) 60 (40,80) 0.74
Positive IGRA 38 (45.2%) 26 (55.3%) 0.28
Patients with low level of
immunoglobulins
IgG (700–1700 mg/dL)* 1 (1.2%) 0 (0%) 1.00
IgA (90–400 mg/dL)* 3 (3.6%) 0 (0%) 0.55
IgM (45–230 mg/dL)* 6 (7.1%) 4 (8.5%) 0.75
C3 (70–150 mg/dL)* 1 (1.2%) 1 (2.1%) 1.00
C4 (10–35 mg/dL)* 1 (1.2%) 1 (2.1%) 1.00
Abbreviations: FANA fluorescent antinuclear antibody test, IGRA IFN-γ release
assay, RF rheumatoid factor, NTM nontuberculous mycobacteria,
BE bronchiectasis, IQR interquartile range.
*Normal ranges.
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known characteristics of patients with NTM lung disease
in the Korean population.
The phenotypic characteristics of patients with NTM
lung disease in this study were similar to those described
in previous reports [3,4,13,14]. Patients with NTM lung
disease were leaner than non-NTM BE patients in our
study. Although the underlying mechanism for the asso-
ciation between NTM lung disease and low BMI is not
well understood, decreased leptin and increased adipo-
nectin, and/or decreased estrogen in older women with
low BMI may account for the increased susceptibility of
these individuals to NTM infections [3]. In addition to
low BMI, scoliosis and pectus excavatum are also fre-
quently observed among NTM lung disease; a higher
rate of scoliosis in patients with NTM lung disease was
also seen in our study. These skeletal abnormalities may
be indicative of an underlying genetic predisposition,
though a precise mechanism linking the two has not
been proposed [15].
M. avium complex and M. abscessus were the most
common organisms isolated, consistent with a previous
report on Korean patients with NTM lung disease [16].
Frequent isolation of M. abscessus is one of the charac-
teristics of Korean patients that differ from patients from
other countries [4]. Mixed infection by two or more
NTM species was observed in 23.8% (20/84) of our pa-
tients; this observation confirmed our previous retro-
spective study showing high rates of mixed NTM
infections [17]. Further examination will be necessary to
determine the clinical significance of these mixed NTM
infections.
We assessed several immunological markers, including
FANA, rheumatoid factor, and serum immunoglobulins,
and compared them with those of BE patients. Although
most immunological markers were similar between the
NTM lung disease and non-NTM BE groups, rheuma-
toid factor was found more commonly in patients with
non-NTM BE. Given that the prevalence of rheumatoid
arthritis and FANA were similar in both groups, the
higher frequency of rheumatoid factor among patients
with BE may be interpreted as a false positive. Various
clinical settings have been shown to cause false positive
results for rheumatoid factor [18].
NTM lung disease patients in our cohort were less
likely to harbor P. aeruginosa than BE patients. Previous
studies have also reported lower incidence of P. aerugi-
nosa in BE or cystic fibrosis patients with NTM
colonization. The underlying mechanism driving this
phenomenon is not yet understood, but the observation
that decontamination of P. aeruginosa yielded the culti-
vation of NTM colonization suggests a level of antagon-
ism between P. aeruginosa and NTM [8,19–22].
A considerable number of NTM lung disease and
non-NTM BE patients in our study reported feelings of
anxiety (23.8% and 21.3%, respectively) as well as depres-
sion (27.4% and 21.3%, respectively). Given that the life-
time prevalence of depression and anxiety disorders in
South Korea are 5.6% and 6.9%, respectively [23],
rates reported here appear significantly higher than
those in the general population. A similar study con-
ducted in the United States showed that 20% of BE
patients had elevated depression-related scores and
38% had elevated anxiety-related scores [24]. Consist-
ently higher rates of depression and anxiety among NTM
lung disease patients and non-NTM BE patients may stem
Table 6 Radiographic characteristics and extent of lesions












3 (2, 4) 4 (3, 9) 0.001
Type of bronchiectasis‡
Tubular 46 (54.8%) 21 (44.7%) 0.28
Varicose 21 (25.0%) 11 (23.4%) 1.00
Cystic 17 (20.2%) 15 (31.9%) 0.14
Paranasal sinus
Normal 62 (73.8%) 33 (70.2%) 0.69
Mucoepithelial thickening 21 (25.0%) 14 (29.8%) 0.55
Air-fluid level or total
haziness
0 (0%) 0 (0%)
Abbreviations: NTM nontuberculous mycobacteria, BE bronchiectasis,
IQR interquartile range.
†Extent of bronchiectasis was scored in each 6 lobe according to involved
percentage of bronchiectatic bronchi. Extent scores range from 0 to 18;
0 if less than 25%, 1 if 25 ~ 49%, 2 if 50 ~ 74%, 3 if 75% or more.
‡Classified based on main lesion.
Table 7 Pulmonary function of 81 patients with NTM lung
disease and 46 non-NTM BE patients*
Number of patients NTM lung
disease





FVC, L 2.8 (2.3,3.4) 2.7 (2.2,3.2) 0.13
% pred. 94 (81,104) 87 (76,97) 0.02
FEV1, L 2.1 (1.8,2.6) 1.8 (1.4,2.2.3) 0.001
% pred. 101 (85,112) 86 (67,99) 0.001
FEV1/FVC% 78 (72,82) 73 (65,81) 0.01
Patterns of ventilation
Normal 52 (64.2%) 20 (43.5%) 0.03
Restrictive 16 (19.8%) 10 (21.7%) 0.82
Obstructive 11 (13.6%) 11 (23.9%) 0.15
Mixed 2 (2.5%) 5 (10.9%) 0.10
*The results of the pulmonary function test could not be performed because
of bloody sputum or patients’ refusal in three NTM lung disease patients and
one non-NTM-BE patient.
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from increased respiratory symptoms as well as other
comorbidities.
Conclusions
In conclusion, the characteristics of Korean NTM lung
disease patients in this study were similar to those of pa-
tients in other countries. The fact that some phenotypic
and clinical characteristics of NTM lung disease patients
were different from those of non-NTM BE patients sug-
gests differences in the immunopathogenesis of NTM
lung disease and non-NTM BE.
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